A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing (Q38016948)

From Wikidata
Jump to navigation Jump to search
scientific article published on July 2012
edit
Language Label Description Also known as
English
A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing
scientific article published on July 2012

    Statements

    A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit